關於「Gsk dividend 2021」標籤，搜尋引擎有相關的訊息討論：

Dividend calendar | GSK。

Dividend timetable for Q4 2021. Announcement date, Wednesday 9 February 2022. Ex-dividend date*, Thursday 24 February 2022. Record date, Friday 25 February ...： 。

GlaxoSmithKline PLC Common Stock (GSK) Dividend History。

Ex-Dividend Date 11/18/2021 · Dividend Yield 4.69% · Annual Dividend $2.064 · P/E Ratio 18.43.： 。

GlaxoSmithKline plc Share Price (GSK) Ordinary 25p - Hargreaves ...。

* Dividend has not yet been paid but has been declared by GlaxoSmithKline plc. This data is provided by Digital Look. HL accepts no responsibility for its ...。

找GSK dividend相關社群貼文資訊。

Announcement date, Wednesday 28 April 2021. Ex-dividend date*, Thursday 20 May 2021. Record date, Friday 21 May 2021.： 。

GSK: Home。

。

GlaxoSmithKline PLC (GSK) Stock Price, News, Quote & History。

Find the latest GlaxoSmithKline PLC (GSK) stock quote, history, news and other vital information to help you with your ... Ex-Dividend Date, May 20, 2021.： 。

GLAXOSMITHKLINE Share Price - GSK - Stockopedia。

評分 89/99 · 評論者：StockopediaFINANCIAL BRIEF: : For the nine months ended 30 September 2021,GlaxoSmithKline plc revenues decreased 3% to £24.59B. Netincome decreased 28% to £3.64B.。

Glaxo CEO Walmsley Buys Time as Strategy Gets Modest Backing。

2021年6月23日 · Emma Walmsley made the case for her leadership of GlaxoSmithKline Plc ... June 23, 2021, 3:11 AM PDT Updated on June 24, 2021, 12:58 AM PDT.： 。

GlaxoSmithKline plc Sponsored ADR - TheStreet。

Find the latest GlaxoSmithKline plc Sponsored ADR, GSK stock market data. Get a full understanding of how GlaxoSmithKline plc Sponsored ADR is performing ...。

GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid ...。

2021年7月15日 · On June 23, 2021, GlaxoSmithKline plc (NYSE: GSK, $40.45, ... assuming Consumer Healthcare dividend payout ratio of 30-50%. New GSK will ...： 。

the ex-dividend-day behavior of stock prices and volume。

2019年5月31日 · This paper presents the wide analysis of the profitability factors of dividend capture strategy on public pharmaceutical companies within a ...